Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on merging with innovative businesses within the life sciences sector. With a highly experienced management team proficient in healthcare investments, OACC aims to harness growth opportunities across various subfields, including healthcare technology, therapeutics, and medical devices. The company emphasizes strategic partnerships and robust due diligence to enhance shareholder value, while its commitment to operational excellence positions it to thrive amid the complexities of the dynamic life sciences landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | 1.33 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.78M |
| Float | $18.37M |
| % Insiders | 0.00% |
| % Institutions | 90.40% |